Abstracts tagged "treatment response"

Abstract Number: 0808 • ACR Convergence 2021
Lower Serum MIP-1β Level Is Associated with CsDMARDs Response in Patients with Early Rheumatoid Arthritis
Isaac Cheng¹, Ho So², Martin Li¹, Evelyn Chow¹, Chun Kwok Wong¹ and Lai-Shan Tam³, ¹The Chinese University of Hong Kong, Hong Kong, Hong Kong, ²CUHK, Hong Kong, China, ³Department of Medicine & Therapeutics, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China (People's Republic)
Background/Purpose: The use of treat-to-target (T2T) strategy in managing early rheumatoid arthritis (ERA) had been highly advocated in the past decades. Various international guideline utilized…
Abstract Number: 1215 • ACR Convergence 2021
Development of a Multivariable Prediction Model for Treatment Response to Etanercept in a Multi-centre Cohort of Patients with Established RA
Michael Stadler¹, Stephanie Ling², Nisha Nair², John Isaacs³, Kimme Hyrich², Ann Morgan⁴, Anthony Wilson⁵, Darren Plant², Anne Barton² and John Bowes², ¹University of Manchester, Preston, United Kingdom, ²University of Manchester, Manchester, United Kingdom, ³Newcastle University, Newcastle upon Tyne, United Kingdom, ⁴University of Leeds, Leeds, United Kingdom, ⁵Center for Arthritis Research, Conway Institute, University College Dublin, Dublin, Ireland
Background/Purpose: RA patients who respond inadequately to first-line DMARDs usually progress to a biologic DMARD. Treatment response to both DMARDs and biologics is heterogeneous within…